相关实验视频

Updated: Feb 28, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

作为体内免疫调节器的-90放射栓塞:临床证据和药理学影响

Shiwei Tang¹, Jia Cai¹, Pandi Wu¹

¹Department of Interventional Radiology, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.

Frontiers in pharmacology

|February 27, 2026

概括

-90 (Y-90) 跨动脉放射栓塞 (TARE) 表明它可以激活免疫系统,而不仅仅是杀死瘤. 这一发现可能会导致新的癌症治疗策略,将TARE与免疫疗法结合起来.

科学领域:

肝胆瘤学肝胆瘤学
干预性放射学是干预性的放射学.
癌症免疫学癌症免疫学

背景情况:

-90 (Y-90) 跨动脉放射栓塞 (TARE) 是肝脏瘤的标准治疗方法.
从历史上看,TARE被认为是一种纯粹的局部区域疗法.
新出现的证据表明,TARE可能具有全身免疫效应.

研究的目的:

审查Y-90 TARE对人体免疫调节效应的证据.
探索对癌症治疗策略的影响.
为了突出TARE作为免疫调节器的潜力.

主要方法:

来自患者的纵向外周血液和瘤组织数据的分析.
对Y-90 TARE和免疫反应的现有临床证据的审查.
在人体内对TARE后免疫变化的活体数据的综合.

主要成果:

Y-90 TARE诱导了短暂的免疫激活,骨髓重塑和适应性免疫干扰.
免疫刺激信号与免疫检查点上调等反调节机制共存.
证据支持Y-90 TARE作为免疫调节器,而不仅仅是细胞毒性.

结论:

Y-90 TARE 影响瘤免疫微环境和全身免疫.
研究结果表明,优化治疗顺序和与免疫疗法结合的策略.
识别TARE的免疫活性可以指导未来的临床试验设计,以更好地控制瘤.

关键词:

肝细胞癌是肝细胞癌.免疫调节的免疫调节免疫疗法组合免疫疗法.瘤免疫力免疫力伊-90的放射性栓塞方式.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...